PREFUNDED COMMON STOCK PURCHASE WARRANT Rezolute, Inc.Rezolute, Inc. • March 14th, 2024 • Pharmaceutical preparations
THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rezolute, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 14th, 2024 • Rezolute, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES EXCHANGE AGREEMENT (this “Agreement”), is dated as of March 8, 2024 (the “Effective Date”), between Rezolute, Inc., a Nevada corporation, (the “Company”) and the subscriber (the “Subscriber”) are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the provisions of Section 3(a)(9), Section 4(a)(2) and/or Regulation D as promulgated by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933 Act”).
